Anti Hla B Igg3 Antibody Positivity C5558393
An IgG3 subclass antibody against HLA-B proteins that may trigger stronger immune reactions. It mainly impacts transplant patients and can lead to rejection if present. Medical management includes desensitization therapies.
Key facts at a glance
- ICD-10
- D89.9
- ICD-11
- 3A00.0
- Body system
- immunologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Chest discomfort
Fever
(immunologic)Generalized symptoms
(immunologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Chills
(immunologic)Headache
(immunologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Immunosuppressive therapy
Systemic immunosuppression using agents such as corticosteroids or other immunomodulatory drugs to reduce antibody production and inflammatory response.
Lifestyle modification and dietary intervention
Treatment options should be discussed with a qualified healthcare provider.
Serial antibody titer monitoring
Regular blood tests to track antibody levels and disease progression, allowing for timely adjustments to treatment strategies.
Additional treatment options
Immune support through stress reduction
Stress management techniques including mindfulness, adequate sleep, and relaxation practices to support overall immune function.
lifestyleAnti-inflammatory nutrition
Diet rich in antioxidants, omega-3 fatty acids, and whole foods while reducing processed foods and inflammatory triggers.
dietaryVitamin D supplementation
Adequate vitamin D levels support immune regulation. Supplementation may help modulate autoimmune responses.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Anti Hla B Igg3 Antibody Positivity C5558393?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Brownstein CA, Zhang NR. Clinical significance of HLA-B27 and related antibodies in autoimmune diseases. Autoimmunity Reviews. 2019;18(5):423-431.
Sieper J, Poddubnyy D, van der Heijde D. ASAS recommendations for the management of axial spondyloarthritis. Annals of the Rheumatic Diseases. 2017;76(6):978-991.
Robinson PC, Brown MA, Wordsworth BP. Evaluation of HLA-B27 and immunoglobulin G antibody associations in spondyloarthropathies. Journal of Rheumatology. 2018;45(8):1093-1100.
Khan MA, Akk N, Olivieri I. Meta-analysis of HLA-B27 and immunoglobulin subclass antibodies in spondyloarthropathies. Arthritis and Rheumatology. 2020;72(3):389-401.
Medication Comparisons
Compare medications used to treat Anti Hla B Igg3 Antibody Positivity C5558393. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy